D. E. Shaw & Co., Inc. Quidel Ortho Corp Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Quidel Ortho Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,006,591 shares of QDEL stock, worth $50.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,006,591

Previous 1,343,025 49.41%

Holding current value

$50.5 Million

Previous $47 Million 23.13%

% of portfolio

0.05%

Previous 0.05%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.46 - $37.42 $16.2 Million - $24.8 Million	663,566 Added 49.41%	2,006,591 $57.8 Million
Q1 2025 May 15, 2025	SELL	$34.78 - $47.61 $13.4 Million - $18.4 Million	-385,588 Reduced 22.31%	1,343,025 $47 Million
Q4 2024 Feb 14, 2025	BUY	$36.18 - $44.84 $1.84 Million - $2.28 Million	50,775 Added 3.03%	1,728,613 $77 Million
Q3 2024 Nov 14, 2024	BUY	$29.96 - $46.4 $3.63 Million - $5.62 Million	121,194 Added 7.79%	1,677,838 $76.5 Million
Q2 2024 Aug 14, 2024	BUY	$32.9 - $47.0 $35.6 Million - $50.8 Million	1,081,364 Added 227.52%	1,556,644 $51.7 Million
Q1 2024 May 15, 2024	BUY	$41.76 - $74.73 $19.8 Million - $35.5 Million	475,280 New	475,280 $22.8 Million
Q4 2022 Feb 14, 2023	SELL	$66.93 - $97.5 $765,746 - $1.12 Million	-11,441 Reduced 72.68%	4,300 $368,000
Q3 2022 Nov 14, 2022	SELL	$69.86 - $107.63 $1.85 Million - $2.85 Million	-26,452 Reduced 62.69%	15,741 $1.13 Million
Q2 2022 Aug 15, 2022	BUY	$89.06 - $117.64 $3.76 Million - $4.96 Million	42,193 New	42,193 $4.1 Million

Others Institutions Holding QDEL

# of Institutions

301

Shares Held

72.4M

Call Options Held

603K

Put Options Held

359K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $1.69B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account